[Immune therapy trial with Corynebacterium in patients with E.N.T. cancer. (Code name of the trial: "Reticulo-stimuline")].
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003352:Corynebacterium / Q000276:immunology*; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D010038:Otorhinolaryngologic Diseases / Q000276:immunology / Q000401:mortality / Q000628:therapy*
D001428:Bacterial Vaccines
Essai thérapeutique immunitaire par le Corynebacterium chez les malades porteurs d'un cancer de la sphère O.R.L. (Nom de code de l'essai: "réticulo-stimuline").